It is crucial to confirm the conservation of BDNF's role in AD models, its applicability across different brain regions (Du et al., 2003), and its interactions with other adaptive myelination cues such as glutamate in vivo (Lundgaard et al., 2013). The gene discussed is BDNF; the disease is Alzheimer disease.